Explain this page
Arphra AIPlain-English read on Zimmer Biomet Holdings, Inc.’s valuation06-08today
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript7d
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript33d
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End34d
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End34d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$282.44
+221.13% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
8bull8bear
±5% threshold
Analyst PT consensus: $97.90 (+11.31%)
Candlestick · 1Y
Open in chart workstation →ZBH
88.57-3.90%H 108.29L 79.12MA50 87.79MA200 93.41Avg vol 2.0M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.70% | -2.06% | +5.08% | -5.63% | -4.85% | -2.19% | -4.57% | -38.32% | -42.74% | -22.13% | +204.64% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$1.1M
8 txns
Net flow
−$1.1M
Aftermarket
LiveLast trade
$87.98
249 sh
Bid
$87.90
10 sh
Ask
$87.99
27 sh
Spread
$0.090
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $2.09B | $238.1M | $1.22 |
| Q4 Dec 2025 | $2.24B | $139.5M | $0.70 |
| Q3 Sep 2025 | $2B | $230.9M | $1.16 |
| Q2 Jun 2025 | $2.08B | $152.8M | $0.77 |
| Q1 Mar 2025 | $1.91B | $182M | $0.91 |
| Q4 Dec 2024 | $2.02B | $239.5M | $1.20 |
Sector & industry today
LiveSectors
- Financial Services+1.46%
- Energy+1.01%
- Utilities+0.77%
- Communication Services+0.45%
- Technology+0.35%
- Consumer Defensive+0.22%
- Industrials+0.08%
- Healthcare-0.28%
- Real Estate-0.35%
- Consumer Cyclical-0.36%
- Basic Materials-0.87%
Top industries (issuer's industry highlighted)
- Medical - Devices-0.09%
- Oil & Gas Energy+5.83%
- Department Stores-5.42%
- Luxury Goods+3.58%
- Software - Infrastructure+3.24%
- Communication Equipment-2.94%
- Medical - Equipment & Services+2.88%
- Trucking-2.86%
- Solar-2.62%
- Electronic Gaming & Multimedia+2.61%
- Steel-2.61%
- Coal-2.46%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$97.90
+11.31% upside
Low
$83.00
Median
$93.50
High
$120.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 08, 2026
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 13, 2026
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year Endprnewswire.com·May 12, 2026
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year Endprnewswire.com·May 12, 2026
- Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Termzacks.com·May 04, 2026
- Here's Why Zimmer Biomet (ZBH) is a Strong Value Stockzacks.com·May 01, 2026
Peers
- UTHRUnited Therapeutics Corporation$570.40$25B
- DXCMDexCom, Inc.$61.35$23.67B
- DGXQuest Diagnostics Incorporated$192.67$21.33B
- WSTWest Pharmaceutical Services, Inc.$300.68$21.24B
- LHLabcorp Holdings Inc.$255.84$21.06B
- STESTERIS plc$214.40$21.04B
- ILMNIllumina, Inc.$135.78$20.63B
- INCYIncyte Corporation$96.91$19.36B
Total assets
$23.09B
Total debt
$7.52B
Cash & equiv
$591.9M
Operating CF
$1.7B
Free cash flow
$1.47B
Buybacks
-$487M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Winkler Lori officer: SVP and CHRO | Sell | 2,650 | $250.85K | Mar 12, 2026 |
Yi Sang officer: Group President, Asia Pacific | Sell | 1,000 | $96.49K | Feb 12, 2026 |
Yi Sang officer: Group President, Asia Pacific | Sell | 1,200 | $124.3K | Sep 11, 2025 |
Winkler Lori officer: SVP and CHRO | Sell | 1,500 | $156.23K | Sep 08, 2025 |
Winkler Lori officer: SVP and CHRO | Sell | 1,500 | $153.74K | Aug 18, 2025 |
Yi Sang officer: Group President, Asia Pacific | Sell | 800 | $74.01K | Jun 13, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $8.23B | $1.36B | $705.2M | $3.55 | +8.57% |
| FY 2024 | $7.68B | $1.29B | $903.8M | $4.43 | +11.77% |
| FY 2023 | $7.39B | $1.28B | $1.02B | $4.88 | +13.85% |
| FY 2022 | $6.94B | $696.3M | $231.4M | $1.10 | +3.33% |
| FY 2021 | $6.83B | $860.3M | $401.6M | $1.91 | +5.88% |